Statistics for Citius Pharmaceuticals (id:5456 CTXR)
Valuation metrics
Market cap
40.52M
Enterprise value
19.15M
Trailing P/E (ttm)
-0.61
Forward P/E
1.18
PEG ratio
1.18
Price/Sales (ttm)
Price/Book (mrq)
0.47
Enterprise Value/Revenue
Enterprise Value/EBITDA
-0.47
Overview
Shares outstanding
180.72M
Float
158.25M
Shares short
11.79M
% Held by insiders
0.07%
% Held by institutions
0.13%
Average volume (10 days)
4.50M
Average volume (90 days)
Price summary
52-Week low
0.11
52-Week high
1.07
52-Week change
-490.43%
Beta
1.66
50-Day moving average
0.43
200-Day moving average
0.65
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
June 09th, 2017
Ex-dividend date
Last split factor
2:1
Last split date
June 09th, 2017
Financials
Fiscal yearFiscal year ends
September 30th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-24.74%
Return on equity
-41.49%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-41,067,916.00
Net income to common (ttm)
-39,765,352.00
Diluted EPS (ttm)
-0.24
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
17.91M
Total cash per share (mrq)
0.10
Total debt (mrq)
320.01K
Total Debt/Equity (mrq)
0.37
Current ratio (mrq)
674.50%
Book value per share (mrq)
0.47
Cash flow
Cash flow statement
-29,088,902.00
Levered free cash flow (LFCF)
-16,828,150.00